DIFFUSE UVEAL MELANOCYTIC PROLIFERATION

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting DIFFUSE UVEAL MELANOCYTIC PROLIFERATION:

# Drug Count
0 PEMBROLIZUMAB 8
1 DURVALUMAB 6
2 BEVACIZUMAB 2
3 CARBOPLATIN 2
4 NINTEDANIB 2
5 PACLITAXEL 2
6 PACLITAXEL (AIBUMIN-BOUND) 2
7 ACETAMINOPHEN 1
8 ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE 1
9 ANTACID 1
See all common drugs associated with DIFFUSE UVEAL MELANOCYTIC PROLIFERATION

DIFFUSE UVEAL MELANOCYTIC PROLIFERATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DORZOLAMIDE HCL 1 0.0009
1 CEMIPLIMAB-RWLC 1 0.0005
2 DURVALUMAB 6 0.0003
3 LOTEPREDNOL ETABONATE 1 0.0002
4 DORZOLAMIDE 1 0.0001
5 TRAVOPROST 1 0.0001
6 PEMBROLIZUMAB 8 0.0001
7 NINTEDANIB 2 0.0001
8 BRIMONIDINE TARTRATE 1 0.0001
9 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
See all drugs enriched for association with DIFFUSE UVEAL MELANOCYTIC PROLIFERATION